Diagnoptics Technologies BV

Aarhusweg 4-9, 9723 JJ Groningen

Telephone +31 50 5890612
Fax +31 50 5890613

This company is co-exhibitor of
Task Force Health Care

Trade fair hall

  • Hall 15 / F55
 Interactive Plan

Hall map

MEDICA 2016 hall map (Hall 15): stand F55

Fairground map

MEDICA 2016 fairground map: Hall 15

Our range of products

Product categories

  • 03  Diagnostics
  • 03.01  Clinical chemistry
  • 03.01.14  Rapid tests - clinical chemistry

Rapid tests - clinical chemistry

  • 03  Diagnostics
  • 03.01  Clinical chemistry
  • 03.01.14  Rapid tests - clinical chemistry
  •  Point of care - testing systems

Point of care - testing systems

About us

Company details

Established in 2003, Diagnoptics is the pioneer and inventor of cutting edge diagnostic devices that can non-invasively diagnose and assess cardiovascular risk and risk of diabetes. Its technological advance in detecting fluorescence of Advanced Glycation Endproducts (AGEs) has led to the invention of the AGE Reader - a state of art diagnostic device which can determine the tissue accumulation of AGEs in 12 seconds.

AGEs are essential biomarkers of metabolic and glycemic stress and have been implicated as causative factors in the progression of a host of age-related diseases, such as atherosclerosis, diabetes, renal failure and Alzheimer. The amount of AGEs in tissue serves as an important cardiovascular risk predictor. The AGE Reader measurements allows the doctor to adjust the treatment for high-risk patients as soon as possible.

More Less

Company data

Export content

> 75%

Number of employees




Area of business
  • Electromedical equipment / Medical Technology
  • Diagnostics